BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 and BMP Peptides being used for injuries and cartilage repair There seems to be a current trend with people taking peptides for injuries. Especially when it comes to cartilage FDA Peptide Reclassification 2026: What It Means for Providers The Peptide Problem MASS Research Review